Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease

CEA, CA19-9 and CA50 are tumour associated antigens defined by monoclonal antibodies which have been raised against adenocarcinoma cell lines. The aim of this study was to determine whether their combined use could improve diagnostic accuracy in patients with primary and secondary liver tumours. An...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lucarotti, M. E., Rothnie, N. D., Kelly, S. B., Hershman, M. J., Johanssen, C., Nilsson, O., Lindholm, L., Wood, C. B., Williamson, R. C. N., Habib, N. A.
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 1991
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442938/
https://ncbi.nlm.nih.gov/pubmed/1777407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/1991/23874
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы